Home
About
Overview
Sharing Data
ORCID
Help
History (6)
Molecular abnormalities in lung cancer.
Molecular alterations in lung cancer. Impact on prognosis.
Phase I Dose-Escalation and -Expansion Study of Telisotuzumab (ABT-700), an Anti-c-Met Antibody, in Patients with Advanced Solid Tumors.
Prognostic value of metabolic tumor burden on 18F-FDG PET in nonsurgical patients with non-small cell lung cancer.
Immunometabolic Status of COVID-19 Cancer Patients.
See All 6 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Immunometabolic Status of COVID-19 Cancer Patients.
Immunometabolic Status of COVID-19 Cancer Patients. Physiol Rev. 2020 10 01; 100(4):1839-1850.
View in:
PubMed
subject areas
Animals
Betacoronavirus
Coronavirus Infections
Cytokines
Humans
Neoplasms
Nicotinamide Phosphoribosyltransferase
Pandemics
Peptidyl-Dipeptidase A
Pneumonia, Viral
authors with profiles
Marina Chiara Garassino